Clinical course and risk factors for infection in severe forms of alcohol-related liver disease

Link to article at PubMed

Hepatology. 2021 May 28. doi: 10.1002/hep.31984. Online ahead of print.


BACKGROUND & AIMS: Infection is a major driver of mortality in patients with advanced alcohol-related liver disease (ALD). The epidemiology and clinical course of infected patients with life-threatening forms of ALD, including severe alcoholic hepatitis (sAH) and decompensated alcoholic cirrhosis (DAC), and specific risk factors for infection remain mostly unknown.

APPROACH & RESULTS: In this observational study, we assessed all infectious episodes occurring within a 90-day period from diagnosis in all consecutive patients with biopsy-proven sAH (mDF≥32, MELD≥18) and DAC (MELD≥18), without alcoholic hepatitis, in our tertiary hospital between 2003 and 2016. A total of 207 patients were included, 139 with sAH and 68 with DAC. One hundred seventeen(84%) patients with sAH and 41(60%) patients with DAC experienced at least one infection episode at 90 days(p<0.001). In multivariable analysis, factors associated with the development of infection were the presence of sAH and baseline MELD score. Bacterial infections represented the most common infection in the two groups, and only MELD score was independently associated with the occurrence of bacterial infection. In both groups, pneumonia was the most prevalent bacterial infection and Gram-negative bacilli were the main pathogens. Invasive fungal infections (IFI) occurred in 20(14.5%) patients with sAH and 3(4.5%) with DAC patients(p<0.05). Multivariable regression showed that younger age, higher MELD, and corticosteroid therapy were independently associated with IFI. The 90-day cumulative incidence of death in infected patients with sAH and DAC were 46% and 41.5% respectively(p=0.43).

CONCLUSIONS: Patients with sAH are more susceptible to develop infection than those with DAC. In life-threatening forms of ALD, infected patients share a similar mortality rate. Corticosteroid treatment, not sAH, seems to be the main risk factor triggering IFI.

PMID:34046927 | DOI:10.1002/hep.31984

Leave a Reply

Your email address will not be published.